1. Promise of hypoxia-targeted tracers in metastatic lymph node imaging

   • Shreya Goel
   • Sixiang Shi

   Editorial 22 August 2022 Pages: 4293 - 4297

2. A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model

   • Taeko Kimura
   • Maiko Ono
   • Makoto Higuchi

   Original Article 08 July 2022 Pages: 4298 - 4311

   

3. Preclinical and first-in-human evaluation of ¹⁸F-labeled D-peptide antagonist for PD-L1 status imaging with PET

   • Ming Zhou
   • Xiaobo Wang
   • Shuo Hu

   Original Article 14 July 2022 Pages: 4312 - 4324

   

4. PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe

   • Xiaojing Shi
   • Pengfei Xu
   • Zhenhua Hu

   Original Article 15 July 2022 Pages: 4325 - 4337

   

5. X-ray multiscale 3D neuroimaging to quantify cellular aging and neurodegeneration postmortem in a model of Alzheimer’s disease

   • Giacomo E. Barbone
   • Alberto Bravin
   • Paola Coan

   Original Article Open access 19 July 2022 Pages: 4338 - 4357

   

6. Usefulness of ¹⁸F-FPP-RGD₂ PET in pathophysiological evaluation of lung fibrosis using a bleomycin-induced rat model

   • Shuichi Hiroyama
   • Keiko Matsunaga
   • Kohji Abe

   Original Article 25 July 2022 Pages: 4358 - 4368

   

7. Hetero-bivalent agents targeting FAP and PSMA

   • Srikanth Boinapally
   • Alla Lisok
   • Sangeeta Ray Banerjee

   Original Article 15 August 2022 Pages: 4369 - 4381

   

8. Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma

   • Yingli Fu
   • Jing Yu
   • George Sgouros

   Original Article 09 July 2022 Pages: 4382 - 4393

   

9. Pilot study of a novel nanobody ⁶⁸ Ga-NODAGA-SNA006 for instant PET imaging of CD8⁺ T cells

   • Yan Wang
   • Chao Wang
   • Liyan Miao

   Original Article 13 July 2022 Pages: 4394 - 4405

   

10. Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer

    • Feredun Azari
    • Gregory Kennedy
    • Sunil Singhal

    Original Article 25 July 2022 Pages: 4406 - 4418

    

11. Feasibility of in vivo CAR T cells tracking using streptavidin–biotin-paired positron emission tomography

    • Donghui Pan
    • Yan Wang
    • Min Yang

    Original Article 29 July 2022 Pages: 4419 - 4426

    

12. Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy

    • Wenhui Huang
    • Kun Wang
    • Jie Tian

    Original Article 04 August 2022 Pages: 4427 - 4439

    

13. Safety of [¹⁷⁷Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity

    • Eline A. M. Ruigrok
    • Marjolein Verhoeven
    • Simone U. Dalm

    Original Article Open access 11 August 2022 Pages: 4440 - 4451

    

14. Application of artificial intelligence in nuclear medicine and molecular imaging: a review of current status and future perspectives for clinical translation

    • Dimitris Visvikis
    • Philippe Lambin
    • Jan Pruim

    Review Article Open access 09 July 2022 Pages: 4452 - 4463

15. An encoder-decoder network for direct image reconstruction on sinograms of a long axial field of view PET

    • Ruiyao Ma
    • Jiaxi Hu
    • Kuangyu Shi

    Original Article 11 July 2022 Pages: 4464 - 4477

    

16. Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment

    • E. Doering
    • M. C. Hoenig
    • for the Alzheimer’s Disease Neuroimaging Initiative

    Original Article Open access 14 July 2022 Pages: 4478 - 4489

    

17. Quantitative evaluation of a deep learning-based framework to generate whole-body attenuation maps using LSO background radiation in long axial FOV PET scanners

    • Hasan Sari
    • Mohammadreza Teimoorisichani
    • Axel Rominger

    Original Article Open access 19 July 2022 Pages: 4490 - 4502

    

18. Artificial intelligence guided enhancement of digital PET: scans as fast as CT?

    • René Hosch
    • Manuel Weber
    • David Kersting

    Original Article Open access 29 July 2022 Pages: 4503 - 4515

    

19. Preclinical evaluation of [¹⁸F]FDG-PET as a biomarker of lymphoid tissue disease and inflammation in Zika virus infection

    • Carla Bianca Luena Victorio
    • Joanne Ong
    • Ann-Marie Chacko

    Original Article Open access 25 July 2022 Pages: 4516 - 4528

    

20. Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens

    • Peili Cen
    • Youyou Zhou
    • Mei Tian

    Review Article Open access 04 July 2022 Pages: 4529 - 4550

    

21. Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study

    • Milena Sales Pitombeira
    • Michel Koole
    • Daniele de Paula Faria

    Original Article 15 July 2022 Pages: 4551 - 4566

    

22. Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer’s continuum

    • Gemma Salvadó
    • Marta Milà-Alomà
    • on behalf of the ALFA Study

    Original Article Open access 18 July 2022 Pages: 4567 - 4579

    

23. Long-term test-retest of cerebral [¹⁸F]MK-6240 binding and longitudinal evaluation of extracerebral tracer uptake in healthy controls and amnestic MCI patients

    • Greet Vanderlinden
    • Nathalie Mertens
    • Koen Van Laere

    Original Article 19 July 2022 Pages: 4580 - 4588

    

24. Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer’s disease: additional results from the AMBAR study

    • Gemma Cuberas-Borrós
    • Isabel Roca
    • Antonio Páez

    Original Article Open access 22 July 2022 Pages: 4589 - 4600

    

25. Noninvasive photoacoustic computed tomography/ultrasound imaging to identify high-risk atherosclerotic plaques

    • Xuewei Liu
    • Rongkang Gao
    • Jiancheng Xiu

    Original Article 23 July 2022 Pages: 4601 - 4615

    

26. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine

    • Circe D. van der Heide
    • Simone U. Dalm

    Review Article Open access 05 July 2022 Pages: 4616 - 4641

    

27. Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features

    • Jakoba J. Eertink
    • Gerben J. C. Zwezerijnen
    • Ronald Boellaard

    Original Article Open access 04 August 2022 Pages: 4642 - 4651

    

28. EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data

    • Joyce van Sluis
    • Johannes H. van Snick
    • Charalampos Tsoumpas

    Original Article Open access 25 July 2022 Pages: 4652 - 4660

    

29. The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review

    • Zahra Kiamanesh
    • Narjess Ayati
    • Andrew M. Scott

    Original Article Open access 06 August 2022 Pages: 4661 - 4676

    

30. Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [¹⁸F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma

    • Otto M. Henriksen
    • Adam E. Hansen
    • Ian Law

    Original Article Open access 30 July 2022 Pages: 4677 - 4691

    

31. Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [¹⁸F]FDG PET/CT imaging: quantitative analysis of [¹⁸F]FDG uptake in primary tumors and metastatic lymph nodes

    • DaQuan Wang
    • Xu Zhang
    • Hui Liu

    Original Article 11 July 2022 Pages: 4692 - 4704

    

32. Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery

    • Joey Roosen
    • Lovisa E. L. Westlund Gotby
    • J. Frank W. Nijsen

    Original Article Open access 13 July 2022 Pages: 4705 - 4715

    

33. Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

    • Osman Öcal
    • Kerstin Schütte
    • Max Seidensticker

    Original Article Open access 02 August 2022 Pages: 4716 - 4726

    

34. mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease

    • Philipp E. Hartrampf
    • Ralph A. Bundschuh
    • Rudolf A. Werner

    Original Article Open access 19 July 2022 Pages: 4727 - 4735

    

35. [⁸⁹Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates

    • Florian Rosar
    • Andrea Schaefer-Schuler
    • Samer Ezziddin

    Original Article Open access 05 August 2022 Pages: 4736 - 4747

    

36. ¹⁸F-FDG PET/CT findings of mesenchymal hamartoma of the liver in an adolescent

    • Congcong Yu
    • Shuang Wu
    • Mei Tian

    Image of the Month 25 June 2022 Pages: 4748 - 4749

    

37. Use of [¹¹C]choline PET/CT for visualization of four hyperactive parathyroid glands in a patient with renal hyperparathyroidism

    • Matti Raitza
    • Aziz A. N. Alshalali
    • Riemer H. J. A. Slart

    Image of the Month Open access 28 June 2022 Pages: 4750 - 4751

    

38. Visualisation of pelvic autonomic nerves using NIR-II fluorescence imaging

    • Qiaojun Qu
    • Huilong Nie
    • Jie Tian

    Image of the Month 13 July 2022 Pages: 4752 - 4754

    

39. Correction to: Hetero-bivalent agents targeting FAP and PSMA

    • Srikanth Boinapally
    • Alla Lisok
    • Sangeeta Ray Banerjee

    Correction 31 August 2022 Pages: 4755 - 4755